{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2023-03-01T17:31:20.000+01:00"
            }
        ],
        "firstPublicationDate": "2022-03-01T11:02:39.000+01:00",
        "lastUpdateDate": "2024-06-28T08:24:18.000+02:00",
        "registerEntryVersions": [
            {
                "legislation": "GL2024",
                "registerEntryId": 31681,
                "validFromDate": "2024-06-28T08:24:18.000+02:00",
                "version": 11,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 31769,
                "validFromDate": "2024-04-30T11:18:07.000+02:00",
                "validUntilDate": "2024-06-28T08:24:18.000+02:00",
                "version": 10,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 30464,
                "validFromDate": "2024-03-26T09:29:06.000+01:00",
                "validUntilDate": "2024-04-30T11:18:07.000+02:00",
                "version": 9,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 26338,
                "validFromDate": "2023-10-23T11:31:02.000+02:00",
                "validUntilDate": "2024-03-26T09:29:06.000+01:00",
                "version": 8,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 25707,
                "validFromDate": "2023-09-19T09:59:24.000+02:00",
                "validUntilDate": "2023-10-23T11:31:02.000+02:00",
                "version": 7,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 23115,
                "validFromDate": "2023-07-06T15:20:51.000+02:00",
                "validUntilDate": "2023-09-19T09:59:24.000+02:00",
                "version": 6,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 19974,
                "validFromDate": "2023-05-15T14:31:22.000+02:00",
                "validUntilDate": "2023-07-06T15:20:51.000+02:00",
                "version": 5,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 17513,
                "validFromDate": "2023-03-01T17:31:20.000+01:00",
                "validUntilDate": "2023-05-15T14:31:22.000+02:00",
                "version": 4,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": true,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_ORGANIZATION_V2",
            "de": "Sonstiges Unternehmen",
            "en": "Other company"
        },
        "activityDescription": "Die Novo Nordisk Pharma GmbH ist eine Vertriebsgesellschaft des pharmazeutischen \r\nUnternehmens Novo Nordisk, dessen Hauptsitz in D\u00e4nemark liegt. Die Novo Nordisk Pharma \r\nGmbH hat ihren Sitz in Mainz. In Deutschland \u00e4u\u00dfert sich die Novo Nordisk Pharma GmbH zu \r\nverschiedenen Themenfeldern, die ihre unternehmerische T\u00e4tigkeit ber\u00fchren. Dazu z\u00e4hlen \r\nRegelungen zur Markteinf\u00fchrung und Erstattungsf\u00e4higkeit von Arzneimitteln, die \r\nWeiterentwicklung der Versorgung von Menschen mit chronischen Erkrankungen und \r\nindustriepolitische Rahmenbedingungen. \r\n\r\nDie T\u00e4tigkeiten im Rahmen der Interessenvertretung umfassen Gespr\u00e4che mit Vertreterinnen \r\nund Vertretern der Bundesministerien und mit Mitgliedern des Deutschen Bundestages sowie \r\nihren B\u00fcromitarbeiterinnen und -mitarbeitern, parlamentarische Fr\u00fchst\u00fccks- und \r\nAbendveranstaltungen, zu denen zuvor genannte Vertreterinnen und Vertreter geladen werden, Positionspapiere und Stellungnahmen. Dar\u00fcber hinaus vertritt die Novo Nordisk Pharma GmbH ihre Interessen in Verb\u00e4nden.",
        "fieldsOfInterest": [
            {
                "code": "FOI_HEALTH_SUPPLY",
                "de": "Gesundheitsversorgung",
                "en": "Health supply"
            },
            {
                "code": "FOI_ECONOMY_INDUSTRIAL",
                "de": "Industriepolitik",
                "en": "Industrial policy"
            },
            {
                "code": "FOI_HEALTH_PROMOTION",
                "de": "Gesundheitsf\u00f6rderung",
                "en": "Health promotion"
            },
            {
                "code": "FOI_ECONOMY",
                "de": "Wirtschaft",
                "en": "Economy"
            },
            {
                "code": "FOI_HEALTH",
                "de": "Gesundheit",
                "en": "Health"
            },
            {
                "code": "FOI_HEALTH_MEDICINE",
                "de": "Arzneimittel",
                "en": "Medicine"
            }
        ],
        "typesOfExercisingLobbyWork": [
            {
                "code": "SELF_OPERATED_OWN_INTEREST",
                "de": "Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen",
                "en": "Interest representation is self-performed in its own interest"
            },
            {
                "code": "CONTRACTS_OPERATED_BY_THIRD_PARTY",
                "de": "Die Interessenvertretung wird in eigenem Interesse durch die Beauftragung Dritter wahrgenommen",
                "en": "Contracts are awarded to third parties to represent own interests of the company"
            }
        ]
    },
    "annualReports": {
        "annualReportPdfUrl": "https://www.lobbyregister.bundestag.de/media/bd/a1/321524/Jahresbericht-2022.pdf",
        "annualReportPreviousLastFiscalYearExists": true,
        "relatedFiscalYearEnd": "2022-12-31",
        "relatedFiscalYearStart": "2022-01-01"
    },
    "codeOfConduct": {
        "codeOfConductPdfUrl": "https://www.lobbyregister.bundestag.de/media/a0/9a/321523/fsa-kodex-transparenzkodex-2020.pdf",
        "ownCodeOfConduct": true
    },
    "contracts": {
        "contracts": [],
        "contractsPresent": false
    },
    "donators": {
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalDonationsEuro": {
            "from": 0,
            "to": 0
        }
    },
    "employeesInvolvedInLobbying": {
        "employeeFTE": 0.53,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 460001,
            "to": 470000
        },
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "legislation": "GL2024",
    "lobbyistIdentity": {
        "address": {
            "city": "Mainz",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "nationalAdditional1": "Novo Nordisk Pharma GmbH",
            "street": "Isaac-Fulda-Allee",
            "streetNumber": "24",
            "type": "NATIONAL",
            "zipCode": "55124"
        },
        "capitalCityRepresentation": {
            "city": "Berlin",
            "email": "DE-Berlin-Office@novonordisk.com",
            "nationalAdditional1": "Novo Nordisk Pharma GmbH",
            "nationalAdditional2": "c/o Linden Palais",
            "phoneNumber": "+4961319030",
            "street": "Unter den Linden ",
            "streetNumber": "40",
            "type": "NATIONAL",
            "zipCode": "10117"
        },
        "capitalCityRepresentationPresent": true,
        "contactDetails": {
            "emails": [
                {
                    "email": "kd_service@novonordisk.com"
                }
            ],
            "phoneNumber": "+4961319030",
            "websites": [
                {
                    "website": "www.novonordisk.de"
                }
            ]
        },
        "entrustedPersons": [
            {
                "firstName": "Udo",
                "lastName": "Schauder",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Josefin",
                "lastName": "Jantz",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Pia",
                "lastName": "Vornholt",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Wibke",
                "lastName": "Reincke",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Michel",
                "lastName": "Schr\u00f6der",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "entrustedPersonsPresent": true,
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_GMBH",
            "de": "Gesellschaft mit beschr\u00e4nkter Haftung (GmbH)",
            "en": "Limited liability company (GmbH)"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "entrustedPerson": false,
                "firstName": "Jesper",
                "function": "Gesch\u00e4ftsf\u00fchrer",
                "lastName": "Wenzel Larsen",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "membersPresent": false,
        "memberships": [
            {
                "membership": "Verband der forschendenen Arzneimittelhersteller eV (vfa)"
            },
            {
                "membership": "Local American Working Group eV (LAWG)"
            },
            {
                "membership": "Im Puls Think Tank Herz-Kreislauf e.V."
            },
            {
                "membership": "Bundesverband Managed Care (BMC)"
            },
            {
                "membership": "Freiwillige Selbstkontrolle f\u00fcr die Arzneimittelindustrie e.V. (FSA)"
            },
            {
                "membership": "Wirtschaftsforum der SPD e.V."
            },
            {
                "membership": "diabetes.DE - Deutsche Diabetes-Hilfe e.V."
            },
            {
                "membership": "Kindernetzwerke e.V."
            },
            {
                "membership": "Herz-Hirn-Allianz"
            },
            {
                "membership": "Verband der Chemischen Industrie e.V."
            },
            {
                "membership": "Deutsche Rheuma-Liga Bundesverband e. V."
            },
            {
                "membership": "Bundesverband der Unternehmensjuristen e.V."
            },
            {
                "membership": "Stifterverband f\u00fcr die Deutsche Wissenschaft e. V. "
            }
        ],
        "membershipsPresent": true,
        "name": "Novo Nordisk Pharma GmbH"
    },
    "mainFundingSources": {
        "mainFundingSources": [
            {
                "code": "MFS_ECONOMIC_ACTIVITY",
                "de": "Wirtschaftliche T\u00e4tigkeit",
                "en": "Economic activity"
            }
        ],
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "membershipFees": {
        "individualContributors": [],
        "individualContributorsPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalMembershipFees": {
            "from": 0,
            "to": 0
        }
    },
    "publicAllowances": {
        "publicAllowancesPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "registerEntryDetails": {
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R002416/31681",
        "fiscalYearUpdate": {
            "lastFiscalYearUpdate": "2024-06-28T08:24:18.000+02:00"
        },
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/70/37/321525/Lobbyregister-Detailansicht-R002416-2024-06-28_08-24-18.pdf",
        "validFromDate": "2024-06-28T08:24:18.000+02:00",
        "version": 11
    },
    "registerEntryId": 31681,
    "registerNumber": "R002416",
    "regulatoryProjects": {
        "regulatoryProjects": [
            {
                "affectedLaws": [
                    {
                        "shortTitle": "SGB 5",
                        "title": "Sozialgesetzbuch (SGB) F\u00fcnftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477)",
                        "url": "https://www.gesetze-im-internet.de/sgb_5"
                    },
                    {
                        "shortTitle": "AMG",
                        "title": "Gesetz \u00fcber den Verkehr mit Arzneimitteln",
                        "url": "https://www.gesetze-im-internet.de/amg_1976"
                    }
                ],
                "affectedLawsPresent": true,
                "description": "Das Medizinforschungsgesetz sieht Regelungen f\u00fcr einen vertraulichen Erstattungsbetrag f\u00fcr pharmazeutische Unternehmen vor. Die Regelung in der vorgeschlagenen Ausgestaltung lehnen wir ab.",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_MEDICINE",
                        "de": "Arzneimittel",
                        "en": "Medicine"
                    },
                    {
                        "code": "FOI_ECONOMY",
                        "de": "Wirtschaft",
                        "en": "Economy"
                    },
                    {
                        "code": "FOI_ECONOMY_INDUSTRIAL",
                        "de": "Industriepolitik",
                        "en": "Industrial policy"
                    }
                ],
                "printedMatters": [
                    {
                        "documentUrl": "https://dserver.bundestag.de/btd/20/115/2011561.pdf",
                        "issuer": "BT",
                        "leadingMinistries": [
                            {
                                "shortTitle": "BMG",
                                "title": "Bundesministerium f\u00fcr Gesundheit",
                                "url": "https://www.bundesgesundheitsministerium.de/"
                            },
                            {
                                "shortTitle": "BMUV",
                                "title": "Bundesministerium f\u00fcr Umwelt, Naturschutz, nukleare Sicherheit und Verbraucherschutz",
                                "url": "https://www.bmuv.de/"
                            }
                        ],
                        "printingNumber": "20/11561",
                        "projectUrl": "https://dip.bundestag.de/vorgang/medizinforschungsgesetz/310586",
                        "title": "Entwurf eines Medizinforschungsgesetzes"
                    }
                ],
                "printedMattersPresent": true,
                "regulatoryProjectNumber": "RV0008352",
                "statements": [],
                "title": "Medizinforschungsgesetz"
            },
            {
                "affectedLaws": [
                    {
                        "shortTitle": "SGB 5",
                        "title": "Sozialgesetzbuch (SGB) F\u00fcnftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477)",
                        "url": "https://www.gesetze-im-internet.de/sgb_5"
                    }
                ],
                "affectedLawsPresent": true,
                "description": "Das GKV-Finanzstabilisierungsgesetz (GKV-FinStG) hat den Spielraum f\u00fcr Verhandlungsl\u00f6sungen im AMNOG stark eingeschr\u00e4nkt. Wir pl\u00e4dieren daher f\u00fcr die Abschaffung der Leitplanken-Regelung in \u00a7130b Abs. 3 SGB V und die Abschaffung des Kombinationsabschlags in \u00a7130e SGB V.",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_MEDICINE",
                        "de": "Arzneimittel",
                        "en": "Medicine"
                    }
                ],
                "printedMatters": [],
                "printedMattersPresent": false,
                "regulatoryProjectNumber": "RV0008353",
                "statements": [],
                "title": "\u00a7130b SGB V, \u00a7130e SGB V - \"AMNOG-Leitplanken\", Kombinationsabschlag"
            }
        ],
        "regulatoryProjectsPresent": true
    },
    "statements": {
        "statements": [],
        "statementsPresent": false
    }
}